DataForce, TransPerfect’s AI data solutions division, announced its platform support for Digital Imaging and Communication in Medicine (DICOM), which simplifies the process of identifying pathologies or diseases. The new tool processes and annotates medical data provided by pharmaceutical and biotechnology organizations that utilize artificial intelligence.
DICOM files are widely used to manage patient data, and DataForce’s specialized labeling function simplifies the classification and identification of results in X-rays, MRIs, CT scans, and other types of medical imagery. Pharmaceutical, biotechnology and medical device sponsors as well as pathology and diagnostic companies can partner with DataForce to label their datasets and train machine learning models used in applications such as early pathology detection, fast diagnostics, and accelerated product development.
With its rapidly emerging demand and 80% of clinical solutions providers supporting use cases to this end, DataForce serves as an essential mechanism for deep learning AI to minimize data errors by accessing various data points simultaneously.
Xavier Fort, Vice President of DataForce, shared, “We are thrilled to launch DataForce’s DICOM support as it will accelerate progress in the assessment, treatment, and ultimately cures for patients.”
TransPerfect President and CEO Phil Shawe stated, “DataForce‘s DICOM tool is a great example of our team harnessing AI to the benefit of life sciences customers.”
SOURCE: PRNewswire
